𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug combination testing in acute lymphoblastic leukemia using the MTT assay

✍ Scribed by Gertjan J.L. Kaspers; Anjo J.P. Veerman; Rob Pieters; Ina Van Zantwijk; Karel Hählen; Elisabeth R. Van Wering

Book ID
113239837
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
691 KB
Volume
19
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical relevance of in vitro drug resi
Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: The state of the art
✍ Pieters, Rob ;Kaspers, Gertjan J. L. ;Klumper, Edwin ;Veerman, Anjo J.P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 891 KB

## Abstract Nowadays about two‐thirds of children with acute lymphoblastic leukemia (ALL) can be cured with chemotherapy, but one‐third die from the disease. The clinical response of leukemic cells to chemotherapy is roughly due to two factors: the effective drug levels reaching the cells and the r

Preclinical testing of the Akt inhibitor
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia
✍ Camilla Evangelisti; Francesca Ricci; Pierluigi Tazzari; Francesca Chiarini; Mic 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

## Abstract Over the past 20 years, survival rates of T‐cell acute lymphoblastic leukemia (T‐ALL) patients have improved, mainly because of advances in polychemotherapy protocols. Despite these improvements, we still need novel and less toxic treatment strategies targeting aberrantly activated sign